Novonesis A/S (LON:0Q4U)
London flag London · Delayed Price · Currency is GBP · Price in DKK
446.06
+7.49 (1.71%)
At close: May 9, 2025
6.61%
Market Cap 23.52B
Revenue (ttm) 3.39B
Net Income (ttm) 383.57M
Shares Out n/a
EPS (ttm) 1.32
PE Ratio 61.31
Forward PE 29.90
Dividend 0.70 (0.16%)
Ex-Dividend Date Apr 4, 2025
Volume 199,360
Average Volume 459,174
Open 444.20
Previous Close 438.58
Day's Range 440.30 - 447.70
52-Week Range 38.30 - 60.79
Beta 0.56
RSI 70.63
Earnings Date May 8, 2025

About Novonesis

Novonesis A/S produces and sells produces various industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as protein solutions and early lie nutrition. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and profe... [Read more]

Industry Miscellaneous Chemical Products
Founded 1925
Employees 10,582
Stock Exchange London Stock Exchange
Ticker Symbol 0Q4U
Full Company Profile

Financial Performance

In 2024, Novonesis's revenue was 3.83 billion, an increase of 59.58% compared to the previous year's 2.40 billion. Earnings were 305.80 million, a decrease of -24.66%.

Financial numbers in EUR Financial Statements

News

There is no news available yet.